1. Deletion of autophagy-related gene 7 in dopaminergic neurons prevents their loss induced by MPTP
   Xue-Yuan Niu et al, 2016, Neuroscience CrossRef
2. Neurotoxin Mechanisms and Processes Relevant to Parkinson’s Disease: An Update
   Juan Segura-Aguilar et al, 2015, Neurotoxicity Research CrossRef
3. Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in in Vitro Models of Parkinson’s Disease via Up-regulation of the Wnt/β-Catenin Pathway
   Arianna Colini Baldeschi et al, 2018, Frontiers in Aging Neuroscience CrossRef
4. LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson’s disease by interfering with the WNT/β-CATENIN pathway
   Jung-Mou Yang et al, 2018, Toxicology CrossRef
5. Heparanase attenuates axon degeneration following sciatic nerve transection
   Michael J. Whitehead et al, 2018, Scientific Reports CrossRef
6. Dopamine neuron loss by selective deletion of autophagy-related gene 5 is not exacerbated by MPTP toxicity in midbrain
   Yan-Hua Ren et al, 2018, Neuroscience Letters CrossRef
7. Conditional Haploinsufficiency of β-Catenin Aggravates Neuronal Damage in a Paraquat-Based Mouse Model of Parkinson Disease
   Fanpeng Zhao et al, 2019, Molecular Neurobiology CrossRef
8. Inhibition of Wnt/β-catenin signaling attenuates axonal degeneration in models of Parkinson's disease
   Yan-Lin Huang et al, 2022, Neurochemistry International CrossRef
9. Identification of key genes and pathways in Parkinson's disease through integrated analysis
   Jingru Wang et al, 2017, Molecular Medicine Reports CrossRef
10. Developmental pathways linked to the vulnerability of adult midbrain dopaminergic neurons to neurodegeneration
    Nilima Prakash, 2022, Frontiers in Molecular Neuroscience CrossRef
11. Role of heparanase in ARDS through autophagy and exosome pathway (review)
    Fei Feng et al, 2023, Frontiers in Pharmacology CrossRef
12. Targeting the Wnt/β-catenin pathway in neurodegenerative diseases: recent approaches and current challenges
    Annalucia Serafino et al, 2020, Expert Opinion on Drug Discovery CrossRef
13. Want of Wnt in Parkinson’s disease: Could sFRP disrupt interplay between Nurr1 and Wnt signaling?
    Naisarg Gamit et al, 2023, Biochemical Pharmacology CrossRef
14. (D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model
    Ching-Chi Chiu et al, 2020, Cell Death & Disease CrossRef